|Identification of blood microRNAs associated to Parkinsoñs disease|
R Margis, R Margis, CRM Rieder
Journal of biotechnology 152 (3), 96-101, 2011
|DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease|
S Olgiati, M Quadri, M Fang, JPMA Rood, JA Saute, HF Chien, ...
Annals of neurology 79 (2), 244-256, 2016
|Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson’s disease|
LB Wild, DB de Lima, JB Balardin, L Rizzi, BL Giacobbo, HB Oliveira, ...
Journal of neurology 260 (2), 580-589, 2013
|Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers|
MS Medeiros, A Schumacher-Schuh, AM Cardoso, GV Bochi, ...
PLoS One 11 (1), e0146129, 2016
|Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial|
EP Monteiro, LT Franzoni, DM Cubillos, A de Oliveira Fagundes, ...
Scandinavian journal of medicine & science in sports 27 (3), 351-358, 2017
|S100B and NSE serum levels in patients with Parkinson's disease|
DV Schaf, ABL Tort, D Fricke, P Schestatsky, LVC Portela, DO Souza, ...
Parkinsonism & related disorders 11 (1), 39-43, 2005
|DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients|
M Rieck, AF Schumacher-Schuh, V Altmann, CLM Francisconi, ...
Pharmacogenomics 13 (15), 1701-1710, 2012
|LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study|
M Quadri, W Mandemakers, MM Grochowska, R Masius, H Geut, ...
The Lancet Neurology 17 (7), 597-608, 2018
|A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm|
CRM Rieder, P Schestatsky, MP Socal, TL Monte, D Fricke, J Costa, ...
Clinical neuropharmacology 30 (1), 39-42, 2007
|Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´ s disease|
EF Dos Santos, ENB Busanello, A Miglioranza, Â Zanatta, AG Barchak, ...
Metabolic brain disease 24 (2), 257-269, 2009
|Interleukin-6 serum levels in patients with Parkinson’s disease|
KW Hofmann, AFS Schuh, J Saute, R Townsend, D Fricke, R Leke, ...
Neurochemical research 34 (8), 1401-1404, 2009
|Quality of life in a Brazilian sample of patients with Parkinson's disease and their caregivers|
P Schestatsky, VC Zanatto, R Margis, E Chachamovich, M Reche, ...
Brazilian Journal of Psychiatry 28, 209-211, 2006
|A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease|
JAM Saute, RM de Castilhos, TL Monte, AF Schumacher‐Schuh, ...
Movement Disorders 29 (4), 568-573, 2014
|A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)|
C Kieling, CRM Rieder, ACF Silva, JAM Saute, CR Cecchin, TL Monte, ...
European journal of neurology 15 (4), 371-376, 2008
|Hyperhidrosis in Parkinson's disease|
P Schestatsky, J Valls‐Solé, JA Ehlers, CRM Rieder, I Gomes
Movement disorders 21 (10), 1744-1748, 2006
|Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives|
CR Cecchin, AP Pires, CR Rieder, TL Monte, I Silveira, T Carvalho, ...
Public Health Genomics 10 (1), 19-26, 2007
|Cytochrome P450 1B1 mRNA in the human central nervous system.|
CR Rieder, DB Ramsden, AC Williams
Molecular Pathology 51 (3), 138, 1998
|Evaluation of sympathetic skin response in Parkinson's disease|
P Schestatsky, JA Ehlers, CRM Rieder, I Gomes
Parkinsonism & related disorders 12 (8), 486-491, 2006
|Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions|
MP Socal, VE Emmel, CRM Rieder, A Hilbig, ML Saraiva-Pereira, ...
Parkinsonism & related disorders 15 (5), 374-378, 2009
|WHOQOL-OLD assessment of quality of life in elderly patients with Parkinson's disease: influence of sleep and depressive symptoms|
R Margis, KC Donis, SV Schönwald, CRM Rieder
Brazilian Journal of Psychiatry 32, 125-131, 2010